Skip to main content

Table 1 Inhibition of AA release by 10 μM U0126 See "Experimental Procedures" for experimental conditions and methods to determine AA release. Percent inhibition of AA release after 3 min of agonist treatment are average ± S.D. for N experiments preformed in duplicate.

From: Inhibition of the MEK1/ERK pathway reduces arachidonic acid release independently of cPLA2 phosphorylation and translocation

Agonist

% Inhibition

N

100 μM ATP

76.1 ± 6.8

7

1 μM IONO

80.2 ± 5.9

8

10 μM IONO

72.2 ± 7.3

6